We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
The danger of imperfect regulation: OxyContin use in the United States and Canada.
- Authors
Lexchin, Joel; Kohler, Jillian Clare
- Abstract
Drug companies aggressively market their products to increase sales and economic rewards. Different countries have different regulatory regimes for controlling promotion. In the United States control rests directly with the Food and Drug Administration whereas Canada relies on a mixture of voluntary self-regulation and an autonomous agency. Each method has significant weaknesses. We examine these weaknesses by analyzing the promotion of OxyContin (the time release version of the opioid oxycodone) by Purdue in Canada and the United States. We then look at the association between promotion and the misuse and abuse of OxyContin in both countries. Finally, we advance specific recommendations for regulating promotion for drugs that may have a high abuse potential.
- Publication
The International journal of risk & safety in medicine, 2011, Vol 23, Issue 4, p233
- ISSN
1878-6847
- Publication type
Journal Article
- DOI
10.3233/JRS-2011-0539